Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix
Article first published online: 17 JAN 2013
Copyright © 2012 ISUOG. Published by John Wiley & Sons, Ltd.
Ultrasound in Obstetrics & Gynecology
Volume 41, Issue 2, pages 146–151, February 2013
How to Cite
Alfirevic, Z., Owen, J., Carreras Moratonas, E., Sharp, A. N., Szychowski, J. M. and Goya, M. (2013), Vaginal progesterone, cerclage or cervical pessary for preventing preterm birth in asymptomatic singleton pregnant women with a history of preterm birth and a sonographic short cervix. Ultrasound Obstet Gynecol, 41: 146–151. doi: 10.1002/uog.12300
- Issue published online: 31 JAN 2013
- Article first published online: 17 JAN 2013
- Accepted manuscript online: 18 SEP 2012 09:43AM EST
- Manuscript Accepted: 8 AUG 2012
- 2U.S. Food and Drug Admistration. FDA statement Makena. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm249025.htm [Accessed 27 December 2011].
- 5Fetal Medicine Foundation Second Trimester Screening Group. Cervical length and obstetric history predict spontaneous preterm birth: development and validation of a model to provide individualized risk assessment. Ultrasound Obstet Gynecol 2008; 31: 549–554., , , , ;
- 7Vaginal progesterone in women with an asymptomatic sonographic short cervix in the midtrimester decreases preterm delivery and neonatal morbidity: a systematic review and meta-analysis of individual patient data. Am J Obstet Gynecol 2012; 206: 124.e1–19., , , , , , , , , , , , , .
- 8Grobman W for the Eunice Kennedy Shriver NICHD, MFM Units Network. Randomized controlled trial of progesterone treatment for preterm birth prevention in nulliparous women with cervical length less than 30 mm. Am J Obstet Gynecol 2012; 206: S367.